TY - JOUR
T1 - Transoral robotic surgery for salivary carcinomas of the base of tongue
T2 - a multicenter REFCOR study
AU - Poissonnet, Valentine
AU - Chabrillac, Emilien
AU - Segier, Bertille
AU - Gorphe, Philippe
AU - Wong, Stéphanie
AU - Garrel, Renaud
AU - Ferron, Christophe
AU - Kaci, Rachid
AU - de Monès, Erwan
AU - Jegoux, Franck
AU - Schultz, Philippe
AU - Culié, Dorian
AU - Baudouin, Robin
AU - Evrard, Diane
AU - Goffinet, Maxime
AU - Morinière, Sylvain
AU - Mirghani, Haitham
AU - Righini, Christian
AU - Duflo, Suzy
AU - Marie, Jean Paul
AU - Guelfucci, Bruno
AU - Atallah, Sarah
AU - Brenet, Esteban
AU - Bertolus, Chloé
AU - Ceruse, Philippe
AU - Aubry, Karine
AU - Dufour, Xavier
AU - Gallet, Patrice
AU - Bastit, Vianney
AU - Uro-Coste, Emmanuelle
AU - Vergez, Sébastien
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2025.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Transoral robotic surgery (TORS) allows minimally invasive surgical access to the oropharynx. Its benefits are well documented for squamous cell carcinomas, but not for salivary carcinomas. The aim of this study was to describe the French experience of TORS regarding salivary gland carcinomas of the base of tongue (BOT). This was a retrospective multicentric study with a national cohort. We included all patients treated surgically for a BOT salivary gland carcinoma from January 2009 to December 2018. Descriptive analyses were performed. Among the 50 patients included, radical excision was performed through an open approach (OA; n = 33) or using TORS (n = 17). T1–T2 tumors were more common in the TORS-group (76.4% vs 60.6%), and so were low-grade tumors (58.8% vs 38.7%). Surgical margins were <1mm in 46.7% of patients in the TORS-group and 52% of patients in the OA-group. After 51.7 months of follow-up, two patients (11.8%) presented with a local recurrence in the TORS-group, versus eight patients (24.2%) in the OA-group. The rate of tracheostomy was 41.2% in the TORS-group and 63.6% in the OA-group. The rate of gastrostomy was 11.8% in the TORS-group and 36.4% in the OA-group. TORS is an acceptable minimally invasive option for selected BOT salivary carcinomas. It may provide good functional and oncological outcomes in selected cases, despite a high rate of close margins.
AB - Transoral robotic surgery (TORS) allows minimally invasive surgical access to the oropharynx. Its benefits are well documented for squamous cell carcinomas, but not for salivary carcinomas. The aim of this study was to describe the French experience of TORS regarding salivary gland carcinomas of the base of tongue (BOT). This was a retrospective multicentric study with a national cohort. We included all patients treated surgically for a BOT salivary gland carcinoma from January 2009 to December 2018. Descriptive analyses were performed. Among the 50 patients included, radical excision was performed through an open approach (OA; n = 33) or using TORS (n = 17). T1–T2 tumors were more common in the TORS-group (76.4% vs 60.6%), and so were low-grade tumors (58.8% vs 38.7%). Surgical margins were <1mm in 46.7% of patients in the TORS-group and 52% of patients in the OA-group. After 51.7 months of follow-up, two patients (11.8%) presented with a local recurrence in the TORS-group, versus eight patients (24.2%) in the OA-group. The rate of tracheostomy was 41.2% in the TORS-group and 63.6% in the OA-group. The rate of gastrostomy was 11.8% in the TORS-group and 36.4% in the OA-group. TORS is an acceptable minimally invasive option for selected BOT salivary carcinomas. It may provide good functional and oncological outcomes in selected cases, despite a high rate of close margins.
KW - Carcinoma
KW - Glossectomy
KW - Salivary gland neoplasms
KW - Tongue
KW - Transoral robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=105003207332&partnerID=8YFLogxK
U2 - 10.1007/s11701-025-02332-2
DO - 10.1007/s11701-025-02332-2
M3 - Article
C2 - 40234274
AN - SCOPUS:105003207332
SN - 1863-2483
VL - 19
JO - Journal of Robotic Surgery
JF - Journal of Robotic Surgery
IS - 1
M1 - 161
ER -